[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:meningioma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":218,"states":223},"Meningioma",34,31,[8,16,22,29,35,41,47,53,59,65,72,79,86,92,98,104,110,116,121,127,133,139,145,151,157,162,168,173,179,185,191,197,204,211],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05425004","Cabozantinib for Patients With Recurrent or Progressive Meningioma",[12],"Phase 2","RECRUITING","2026-08-26T02:17:05.997056Z","2026-07-05T05:32:16.802025Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07428616","A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma",[12],"2026-08-26T02:16:24.970704Z","2026-05-29T15:36:40.187682Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT07150806","RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma",[26],"Phase 1\u002FPhase 2","2026-08-26T02:17:22.949982Z","2026-05-29T15:36:40.180205Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06557512","Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma",[],"2026-08-26T02:17:41.695983Z","2026-05-05T02:43:29.526897Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07533942","A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma",[12],"2026-08-26T02:19:23.493898Z","2026-05-05T02:43:29.319286Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT04082520","Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy",[12],"2026-08-26T02:15:02.712396Z","2026-05-05T02:43:29.226087Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT02847559","Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma",[12],"2026-08-26T02:18:09.641312Z","2026-05-05T02:43:28.877195Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT05023018","NEO100 and High-Grade Meningioma",[12],"2026-08-26T02:17:25.718160Z","2026-05-05T02:43:27.827246Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT05940493","Abemaciclib in Newly Diagnosed Meningioma Patients",[12],"2026-08-26T02:16:34.792807Z","2026-05-05T02:43:27.433212Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":70,"content_modified":71},"NCT03180268","Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery",[69],"Phase 3","2026-08-26T02:17:18.747857Z","2026-05-05T02:43:27.092603Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":77,"content_modified":78},"NCT06377371","Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE",[76],"Phase 4","2026-08-26T02:18:27.904411Z","2026-05-05T02:43:26.934785Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":84,"content_modified":85},"NCT07165132","Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.",[83],"Phase 1","2026-08-26T02:17:27.435233Z","2026-05-05T02:43:27.257230Z",{"nct_id":87,"title":88,"phases":89,"status":13,"updated_at":90,"content_modified":91},"NCT06132685","Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial",[12],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:26.663660Z",{"nct_id":93,"title":94,"phases":95,"status":13,"updated_at":96,"content_modified":97},"NCT05278208","Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors",[26],"2026-08-26T02:18:21.216897Z","2026-07-24T01:27:14.928126Z",{"nct_id":99,"title":100,"phases":101,"status":13,"updated_at":102,"content_modified":103},"NCT05636618","Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors",[26],"2026-08-26T02:17:03.534765Z","2026-07-05T05:32:16.808808Z",{"nct_id":105,"title":106,"phases":107,"status":13,"updated_at":108,"content_modified":109},"NCT06725758","A Phase 1\u002F2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours",[26],"2026-08-26T02:18:25.327036Z","2026-05-13T02:55:06.568386Z",{"nct_id":111,"title":112,"phases":113,"status":13,"updated_at":114,"content_modified":115},"NCT04374305","Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)",[12],"2026-08-26T02:18:34.622081Z","2026-05-13T02:55:06.248563Z",{"nct_id":117,"title":118,"phases":119,"status":13,"updated_at":90,"content_modified":120},"NCT04278118","Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study",[],"2026-05-05T02:43:29.156766Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT06014905","Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma",[83],"2026-08-26T02:15:52.238965Z","2026-05-05T02:43:29.211730Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT06650163","Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors",[83],"2026-08-26T02:15:17.167444Z","2026-05-05T02:43:27.572146Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":57,"content_modified":138},"NCT05093335","In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET",[137],"Early Phase 1","2026-05-05T02:43:29.185534Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":143,"content_modified":144},"NCT05139277","Evaluation of the CONVIVO System",[],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:29.047316Z",{"nct_id":146,"title":147,"phases":148,"status":13,"updated_at":149,"content_modified":150},"NCT04081701","68-Ga DOTATATE PET\u002FMRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.",[76],"2026-08-26T02:15:09.079045Z","2026-05-05T02:43:27.179150Z",{"nct_id":152,"title":153,"phases":154,"status":13,"updated_at":155,"content_modified":156},"NCT04635657","Cognitive Status After Removal of Skull Base Meningioma",[],"2026-08-26T02:19:06.150683Z","2026-05-29T15:36:40.161346Z",{"nct_id":158,"title":159,"phases":160,"status":13,"updated_at":125,"content_modified":161},"NCT07418775","Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma",[],"2026-05-13T02:55:06.701132Z",{"nct_id":163,"title":164,"phases":165,"status":13,"updated_at":166,"content_modified":167},"NCT05576103","Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients",[],"2026-08-26T02:15:44.309045Z","2026-05-13T02:55:06.363470Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":131,"content_modified":172},"NCT04427384","Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)",[],"2026-05-13T02:55:06.248037Z",{"nct_id":174,"title":175,"phases":176,"status":13,"updated_at":177,"content_modified":178},"NCT04792463","Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome",[],"2026-08-26T02:15:56.561131Z","2026-05-13T02:55:06.269987Z",{"nct_id":180,"title":181,"phases":182,"status":13,"updated_at":183,"content_modified":184},"NCT00598351","Natural History Study of Patients With Neurofibromatosis Type 2",[],"2026-08-26T02:18:07.037408Z","2026-05-13T02:55:06.039407Z",{"nct_id":186,"title":187,"phases":188,"status":13,"updated_at":189,"content_modified":190},"NCT07493447","Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures",[137],"2026-08-26T02:18:38.077159Z","2026-07-05T03:45:20.252798Z",{"nct_id":192,"title":193,"phases":194,"status":13,"updated_at":195,"content_modified":196},"NCT06930846","HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)",[],"2026-08-26T02:16:14.341106Z","2026-05-05T02:43:28.510148Z",{"nct_id":198,"title":199,"phases":200,"status":201,"updated_at":202,"content_modified":203},"NCT04298541","Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC",[12],"NOT_YET_RECRUITING","2026-08-26T02:17:13.277148Z","2026-05-05T02:43:29.225524Z",{"nct_id":205,"title":206,"phases":207,"status":208,"updated_at":209,"content_modified":210},"NCT06501716","ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery",[],"UNKNOWN","2026-08-03T02:45:04.257287Z","2026-05-13T02:55:06.495329Z",{"nct_id":212,"title":213,"phases":214,"status":215,"updated_at":216,"content_modified":217},"NCT04087902","Long-Term Longitudinal QoL in Patients Undergoing EEA",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:02:05.931134Z","2026-05-13T02:55:06.184138Z",[219],{"biomarker":220,"count":221,"slug":222},"Somatostatin Receptor",5,"somatostatin-receptor",[224,228,232,236,240,244,247,250,253,256,259,262,265,269,272,275,278,282,285,288,291,294,297,300],{"state":225,"count":226,"slug":227},"California",13,"california",{"state":229,"count":230,"slug":231},"New York",11,"new-york",{"state":233,"count":234,"slug":235},"Ohio",9,"ohio",{"state":237,"count":238,"slug":239},"Florida",7,"florida",{"state":241,"count":242,"slug":243},"Tennessee",6,"tennessee",{"state":245,"count":221,"slug":246},"Georgia","georgia",{"state":248,"count":221,"slug":249},"Massachusetts","massachusetts",{"state":251,"count":221,"slug":252},"Missouri","missouri",{"state":254,"count":221,"slug":255},"North Carolina","north-carolina",{"state":257,"count":221,"slug":258},"Pennsylvania","pennsylvania",{"state":260,"count":221,"slug":261},"Texas","texas",{"state":263,"count":221,"slug":264},"Virginia","virginia",{"state":266,"count":267,"slug":268},"Arizona",4,"arizona",{"state":270,"count":267,"slug":271},"Kentucky","kentucky",{"state":273,"count":267,"slug":274},"Maryland","maryland",{"state":276,"count":267,"slug":277},"Minnesota","minnesota",{"state":279,"count":280,"slug":281},"Illinois",3,"illinois",{"state":283,"count":280,"slug":284},"Indiana","indiana",{"state":286,"count":280,"slug":287},"Iowa","iowa",{"state":289,"count":280,"slug":290},"Louisiana","louisiana",{"state":292,"count":280,"slug":293},"Michigan","michigan",{"state":295,"count":280,"slug":296},"Nebraska","nebraska",{"state":298,"count":280,"slug":299},"New Hampshire","new-hampshire",{"state":301,"count":280,"slug":302},"Utah","utah"]